IMPORTANT RISK INFORMATION AND INDICATION
What is the most important information I should know about VRAYLAR?
Elderly people with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) taking
antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for treating people with dementia-related psychosis.
VRAYLAR may cause serious , including:
Stroke (which can be fatal) in elderly people with dementia
Neuroleptic malignant syndrome (NMS): Call your healthcare provider right away if you have high
fever; stiff muscles; confusion; changes in pulse, heart rate, or blood pressure; or sweating. These can be
symptoms of a rare but potentially fatal side effect called NMS. VRAYLAR should be stopped if you have NMS
Tardive dyskinesia (TD): Tell your healthcare provider if you cannot control the movements
of your face, tongue, or other body parts. These could be signs of a serious and sometimes permanent side effect called TD. Risk of developing
TD and the chance that it will become permanent are thought to increase the longer a person takes the medicine and the more medicine a
person takes over time. TD can develop even after a person has been taking the medicine for a short time at low doses. TD may partially
or completely go away if you stop taking VRAYLAR. TD may also start after you stop taking VRAYLAR
Late-occurring side effects: VRAYLAR stays in the body for several weeks, even after you stop taking it,
which could affect the timing of when you may experience side effects. Tell your healthcare provider if you have
side effects (eg, uncontrolled movements of the body and face, muscle stiffness, or feelings of restlessness) as these
may occur several weeks after starting or increasing dose of VRAYLAR
Problems with your metabolism, such as:
High blood sugar and diabetes: If you have diabetes or risk factors for diabetes
(eg, being overweight or family history of diabetes), your blood sugar should be tested before you start
VRAYLAR and regularly during treatment. Complications of diabetes can be serious and even life threatening.
Tell your healthcare provider if you have symptoms such as feeling very thirsty or very hungry,
urinating more than usual, or feeling weak
Increased blood cholesterol or triglycerides: Your healthcare provider should
check your cholesterol and triglyceride levels
before and during treatment
Weight gain: Weight gain has been reported with VRAYLAR. Your healthcare
provider should check your weight before and regularly during treatment
Low white blood cell count: Low white blood cell counts have been reported with antipsychotic drugs,
including VRAYLAR. This may increase your risk of infection. Very low white blood cell counts, which
can be fatal, have been reported with other antipsychotics
Decreased blood pressure: You may feel lightheaded or faint when you rise too quickly from a sitting or lying position
Falls: VRAYLAR may increase risk of falls, which could cause fractures or other injuries
Impaired judgment, thinking, and motor skills: Do NOT drive or use dangerous machinery
until you know how VRAYLAR affects you. VRAYLAR may make you drowsy
Increased body temperature: VRAYLAR may make you more sensitive to heat. You may have trouble cooling off.
Be careful when exercising or when doing things likely to cause dehydration or make you warm
Difficulty swallowing: VRAYLAR and medicines like it have been associated with difficulty swallowing
Who should not take VRAYLAR?
Do not take VRAYLAR if you are allergic to any of its ingredients. Get emergency medical help if you are having an
allergic reaction (eg, rash, itching, hives, swelling of the tongue, lip, face or throat).
What should I tell my healthcare provider before taking VRAYLAR?
Tell your healthcare provider about any medical conditions and if you have or have had:
Diabetes or high blood sugar in you or your family
High levels of total cholesterol, triglycerides, or LDL-cholesterol; or low levels of HDL-cholesterol
Seizures or conditions that increase your risk for seizures
Low or high blood pressure
Low white blood cell count
Tell your healthcare provider if you are pregnant, or if you plan to become pregnant. Using VRAYLAR in the third
trimester may cause uncontrolled movements of the body and face, muscle stiffness, or feelings of restlessness and/or
withdrawal symptoms in newborn babies. A special program (National Pregnancy Registry for Atypical Antipsychotics)
collects information on the safety of antipsychotic drugs, including VRAYLAR, during pregnancy. For information,
contact the program at 1-866-961-2388
Tell your healthcare provider about all medicines that you take or have recently taken, including prescriptions,
over-the-counter medicines, and supplements. VRAYLAR may affect the way other medicines work, and
other medicines may affect how VRAYLAR works.
What are the most common side effects of VRAYLAR?
The most common side effects were uncontrolled movements of the body and face, muscle stiffness,
vomiting, indigestion, sleepiness, and restlessness.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all possible side effects of VRAYLAR.
INDICATION AND USAGE
VRAYLAR (cariprazine) is approved for the acute treatment of manic or mixed episodes
associated with bipolar I disorder in adults.